Cervical spine-focused medical device maker Providence Medical today released results from 2 independent studies of its DTrax and Cavux posterior cervical fusion technology, touting significant improvements in pain relief and other benefits.
The 1st study compared the use of the Walnut Creek, Calif.-based company’s DTrax expandable cage system against conservative care for patients with single-level cervical radiculopathy. Results, which were published in World Neurosurgery, indicated significant improvements in VAS neck and arm pain relative to the control points out to 1 year, as well as improvements from baseline in NDI and SF-36.
Researchers in the 2nd study, which was published in Operative Neurosurgery, examined the results of bilateral posterior cervical fusion cages for treating anterior cervical psuedoarthrosis with Providence’s DTrax spinal system and Cavux cervical cages. Results showed improvements in VAS neck and arm scores, as well as NDI scores, Providence Medical said.
“We were delighted to receive notification of these recent publications adding to the growing body of clinical evidence supporting our innovative tissue-sparing posterior cervical fusion technology. We are grateful for the work of these authors and particularly thankful to the patients who volunteered to participate in a randomized controlled trial to study the impact of our novel surgical approach. These independent studies represent two of the more common applications of our cervical fusion technology, and it is encouraging that new clinical evidence continues to support these use cases. We are committed to clinical research and look forward to additional publications moving forward,” CEO Jeff Smith said in a press release.
In May, Providence Medical said it closed a $10.5 million debt agreement with Bridge Bank.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!